C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2002
11/21/2002	US20020174452 Modifying lignan content in plants by transforming plants with vectors containing a DNA sequence encoding one or more proteins integral to the phenylpropanoid pathway leading to G-lignan formation
11/21/2002	US20020174450 Transgenic mice containing cash gene disruptions
11/21/2002	US20020174449 Replacing sex chromosome in animals to be cloned; breeding pairs
11/21/2002	US20020174448 Transgenic expression from a SOCS-3 promoter in vertebrate cells
11/21/2002	US20020174446 Identification of genes involved in alzheimer's disease using drosophila melanogaster
11/21/2002	US20020174096 Interactive correlation of compound information and genomic information
11/21/2002	US20020173642 Human gastric cancer antigen gene and gastric cancer antigen protein
11/21/2002	US20020173641 Nucleotide sequences coding polypeptides for use in human therapeutics, pharmacology and diagnostics
11/21/2002	US20020173638 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of ovarian cancer
11/21/2002	US20020173636 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of diabetes, dietetics, eating disorders, and cachexia
11/21/2002	US20020173635 Secreted expressed sequence tags (sESTs)
11/21/2002	US20020173634 Transposon sequences for use as tools in generating transgenic cell
11/21/2002	US20020173633 Characterization of phenylalanine ammonia-lyase (PAL) gene in wounded lettuce tissue
11/21/2002	US20020173630 33217, a novel human AMP-binding enzyme family member and uses thereof
11/21/2002	US20020173628 Chimeric IL-10 proteins and uses thereof
11/21/2002	US20020173626 Fusion protein for use in the diagnosis, prevention and treatment of liver disorders
11/21/2002	US20020173625 Hybrid polypeptide for use in the treatment and prevention of allergic disorders
11/21/2002	US20020173624 Polypeptide for use in treatment and prevention of liver, nervous system and glandular disorders
11/21/2002	US20020173623 Mammalian cytokines; receptors; related reagents and methods
11/21/2002	US20020173622 Tsg101-GAGp6 interaction and use thereof
11/21/2002	US20020173621 Generation of preferential fusion protein; obtain cell, transform with expression vector coding fusion polypeptide, propagate, express vector, recover fusion protein
11/21/2002	US20020173480 Polynucleotides; analyzing binding between detector and target
11/21/2002	US20020173478 Controlling, prevention gene expression
11/21/2002	US20020173476 Cancer diagnosis
11/21/2002	US20020173475 Methods to inhibit viral replication
11/21/2002	US20020173474 Methods & materials involving dimerization-mediated regulation of biological events
11/21/2002	US20020173461 Methods for enhancing the efficacy of cancer therapy
11/21/2002	US20020173460 Complexing with fibronectins; analyzing, calibration; antiinflammatory agents, respiratory system disorders
11/21/2002	US20020173459 Isolated peptide; antibodies; genetic engineering
11/21/2002	US20020173458 Polypeptides; genetic engineering
11/21/2002	US20020173457 Polypeptides
11/21/2002	US20020173455 23927, a novel human ion channel
11/21/2002	US20020173449 O-superfamily conotoxin peptides
11/21/2002	US20020173045 Method for determining the size of a spherical or elipsoidal molecule
11/21/2002	US20020173039 Packaging systems for human recombinant adenovirus to be used in gene therapy
11/21/2002	US20020173038 Retroviral packaging cassettes amplified in the cytoplasm by autocatalytic togavirus vectors
11/21/2002	US20020173035 Variable region of the monoclonal antibody against the HBV S-surface antigen and a gene encoding the same
11/21/2002	US20020173031 Amplification or reduction of drug resistance in bacteria, yeast, plant of mamalian cells; obtain cell, adjust adenosine triphosphate gradient, monitor drug resistance
11/21/2002	US20020173030 Lenitiviral packaging system for use as tool in genetic engineering
11/21/2002	US20020173025 Human DNase I hyperactive variants
11/21/2002	US20020173022 Polypeptide for use in the diagnosis, prevention and treatment of inflammation and disorders associated with cell proliferation and apoptosis
11/21/2002	US20020173021 Protein for use in the generation of gelled foods and cosmetics
11/21/2002	US20020173020 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferation disorders
11/21/2002	US20020173019 Enzymes for biopolymer production
11/21/2002	US20020173017 Wooden leg gene, promoter and uses thereof
11/21/2002	US20020173014 Generating polybutyrolactones; obtain cell, transform with gene coding enzymes associated biosynthesis of polybutyrolactones, express gene recover polybutyrolactones
11/21/2002	US20020173013 Nucleotide sequences coding polypeptide for use in the generation of S-N-benzylazetidine-2-carboxylic acid
11/21/2002	US20020173011 Generating amino acids for use in pharmocology, feeds and flavoring; obtain escherichia, incubate in nutrient broth, propagate, ferment and recover amino acids
11/21/2002	US20020173008 Recombinant polyketide synthase genes
11/21/2002	US20020173007 Human chemokine polypeptides
11/21/2002	US20020173006 Generating chimeric zinc finger protein; obtain nucleotide sequences coding chimeric protein, transform cells, express nucleotide sequences, recover protein
11/21/2002	US20020173004 Nucleotide sequences coding transport protein for use in the treatment of nervous system disorders
11/21/2002	US20020173003 Directed evolution of microorganisms
11/21/2002	US20020173002 Polypeptide for use in the diagnosis, prevention, and treatment of cancer, inflammation, and disorders associated with retinoid metabolism
11/21/2002	US20020173001 Variant TLR4 nucleic acid and uses thereof
11/21/2002	US20020172999 Novel KIAA1061-like cell adhesion molecule-like proteins and polynucleotides encoding them
11/21/2002	US20020172998 32612, a novel human peptide transporter and uses therefor
11/21/2002	US20020172997 Replication of preefrential nucleotide sequences; obtain nucleotide sequences, insert into vector, incubate with recombinase, recover vector, amplify nucleotide sequences
11/21/2002	US20020172986 23228, a novel human tetraspanin family member and uses thereof
11/21/2002	US20020172985 Cassette for expressing a Toxoplasma gondii P30 protein
11/21/2002	US20020172984 Modulation of sctivity of transmembrane ligand; obtain sample containing tyrosine kinase, incubate with ligand, monitor bological activity, compare to control, adjustment in biological activity indicates modulator
11/21/2002	US20020172982 Glycoprotein for use in diagnosis and treatment of human sexual disorders
11/21/2002	US20020172973 Composite material sheet for analysis of substances originating from living body or analogues thereof
11/21/2002	US20020172968 Biochips comprising nucleic acid/protein conjugates
11/21/2002	US20020172966 Detecting mutation in nucleotide sequences; obtain nucleotide sequences, join to oligomers, transform cells, detect mutations
11/21/2002	US20020172962 Generation of nucleotide sequence ligands; obtain nucleotide sequences mixture, separate nucleotide sequences, amplify nucleotide sequences, incubate with modulator, detect adjustment in binding activity
11/21/2002	US20020172961 Sequencing preferential nucleotide sequences; obtain oligomer, label, digest, separate, perform mass spectrum analysis, determine sequence
11/21/2002	US20020172959 Compositions and methods relating to lung specific genes and proteins
11/21/2002	US20020172958 Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries
11/21/2002	US20020172955 Purifying target nucleotide sequences from sample; obtain nucleotide sequences, incubate with primers, extend nucleotide sequence chain, migrate sample through gel, recover target molecules
11/21/2002	US20020172954 Method for large scale cDNA cloning and sequencing by circulating subtraction
11/21/2002	US20020172949 Method for isolating DNA
11/21/2002	US20020172944 Protein activity screening of clones having dna from uncultivated microorganisms
11/21/2002	US20020172941 Inducing immune response against feline immunodeficiency virus; obtain animal, administer protective agent, detect immunological response against viral infection
11/21/2002	US20020172940 Methods and reagents for isolating biologically active peptides
11/21/2002	US20020172939 DNA, RNA, amino acid sequences for detecting antibodies against retroviruses which are associated with immunodeficiency diseases; diagnosis
11/21/2002	US20020172705 Bioengineered tissue constructs and methods for producing and using thereof
11/21/2002	US20020172690 Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
11/21/2002	US20020172683 Used for therapy of viral pathologies, such as those due to HIV-1 or HIV-2 infections, for screening compounds
11/21/2002	US20020172678 For regulating cellular proliferation and chemotaxis
11/21/2002	US20020172674 Administering formulation selected from a BAFF-R polypeptide or fragment; a chimeric molecule comprising a BAFF-R polypeptide or fragment fused to heterologous amino acid sequence; anti-BAFF-R antibody for inhibiting B-cell growth
11/21/2002	US20020172673 Method for down-regulating IgE
11/21/2002	US20020172670 Used to generate models for elucidating the structure of other polypeptides and for better identifying ligands capable of modulating mannosidase II activity
11/21/2002	US20020172664 Methods of treating Parkinson's disease using recombinant adeno-associated virus virions
11/21/2002	US20020172663 Localized myocardial injection method for treating ischemic myocardium
11/21/2002	US20020172660 For therapy of cancer, viral infections
11/21/2002	DE4336911C2 Verfahren zur Primer-Herstellung und Template-Bank dafür Methods produce the primer and template bank for
11/21/2002	DE10217084A1 Trennung von DNA-Molekülen Separation of DNA molecules
11/21/2002	DE10124057A1 Use of autofluorescent proteins for protecting plants against damaging effects of ultra-violet B radiation, also for characterization of transgenic plants
11/21/2002	DE10123348A1 New DNA construct encoding polypeptide that includes cleavage sites, useful for preparation of pharmaceutical peptides or their mixtures
11/21/2002	DE10122862A1 New nucleic acid that binds to gonadotropin releasing hormone, useful for treating and diagnosing overproduction of hormones, e.g. endometriosis
11/21/2002	DE10122847A1 New nucleic acid that binds to staphylococcal enterotoxin B, useful for treating and diagnosing e.g. septic shock, identified by the SELEX method
11/21/2002	DE10120797A1 Verfahren zur Analyse von Nukleinsäureketten A process for the analysis of nucleic acid chains
11/21/2002	DE10114682A1 Verwendung von raf zur Hemmung von bakteriellen Porin-Faktoren Use of raf inhibition of bacterial porin factors
11/21/2002	DE10100587C1 Inhibiting expression of target genes, e.g. oncogenes, in cells, by introduction of complementary double-stranded oligoribonucleotide, after treating the cell with interferon
11/21/2002	CA2826627A1 Specific binding proteins and uses thereof
11/21/2002	CA2713200A1 Serine o-acetyl transferase
11/21/2002	CA2460603A1 Unigene unidirectional antisense library
11/21/2002	CA2447593A1 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
11/21/2002	CA2447576A1 Use of hmg fragment as anti-inflammatory agents

1 ... 2656 2657 2658 2659 2660 2661 2662 2663 2664 2665 2666 2667 2668 2669 2670 2671 2672 2673 2674 2675 2676 ... 4023